导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -20.52% | 4428/4773 |
| 近一周 | -2.27% | 4209/5467 |
| 近一月 | -12.68% | 5337/5421 |
| 近一季 | -23.51% | 5135/5238 |
| 近半年 | -20.61% | 4472/4931 |
| 近一年 | -14.14% | 3631/4400 |
| 近两年 | 63.10% | 1156/2954 |
| 近三年 | 13.40% | 1664/2253 |
| 成立以来 | 91.28% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.13% 2142/4961 |
0.10% 3210/5312 |
- - |
- - |
| 2025 | 56.64% 303/4813 |
6.72% 588/3635 |
-0.97% 3080/4076 |
50.69% 296/4524 |
-1.64% 2988/4813 |
| 2024 | 0.05% 2089/3463 |
-7.57% 2172/2808 |
-10.10% 2420/3014 |
23.20% 410/3129 |
-2.26% 2021/3463 |
| 2023 | -28.82% 2047/2656 |
-2.62% 2027/2280 |
-5.82% 1538/2385 |
-16.10% 2243/2515 |
-7.50% 2160/2655 |
| 2022 | -29.03% 1584/2207 |
-17.48% 1212/1919 |
21.14% 31/2016 |
-24.39% 1988/2113 |
-6.10% 1978/2208 |
| 2021 | 41.96% 25/1822 |
-12.52% 1148/1255 |
45.55% 7/1330 |
13.03% 94/1466 |
-1.36% 1357/1822 |
| 2020 | - - |
- - |
30.78% 47/1067 |
10.67% 525/1164 |
51.20% 3/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 华夏中证新能源汽车ETF VS. 长安沪深300非周期A(740101) |